REFERENCES
- Altiparmak MR, Gfingör K, Pamuk GE et al. Temporary catheter infections in hemodialysis patients: results from a single center in Turkey. Acta Clin Belg 2004; 59: 345–9
- Lameire N, Wauters JP, Teruel JL, Van Biesen W, Vanholder R. An update on the referral pattern of patients with end-stage renal disease. Kidney Int 2002; 61 (Suppl 80): 27–34
- Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 2002; 17 (Suppl 7): 7–15
- Vanholder R. Vascular access. Int J Artif Organs 2002; 25: 347–53
- Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int 1998; 54: 1029–40
- Dasgupta MK. Biofilms and infection in dialysis patients. Semin Dial 2002; 15: 338–46
- O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759–69
- III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37: S137–S181
- Vanholder R. Vascular access: care and monitoring of function. Nephrol Dial Transplant 2001; 16: 1542–5
- Rodriguez JA, Armadans L, Ferrer E et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15: 402–8
- Ravani P. Marcelli D, Malberti F. Vascular access surgery ma-naged by renal physicians: the choice of native arteriovenous fistulas for hemodialysis. Am J Kidney Dis. 2002; 40: 1264–76
- De Meester J, Vanholder R, De Roose J, Ringoir S. Factors and complications affecting catheter and technique survival with per-manent single-lumen dialysis catheters. Nephrol Dial Transplant 1994; 9: 678–83
- Vanholder V, Hoenich N, Ringoir S. Morbidity and mortality of central venous catheter hemodialysis: a review of 10 years' experience. Nephron 1987; 47: 274–9
- Section VI. Haemodialysis-associated infection. Nephrol Dial Transplant 2002; 17 Suppl 7: 72–87
- Vanholder R, Van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20: 477–80
- El Solh N, Davi M, Morvan A et al. Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decre-ased susceptibility or resistance to glycopeptides. J Antimicrob Chemother 2003; 52: 691–4
- Sesso R, Barbosa D, Leme IL et al. Staphylococcus aureus prop-hylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9: 1085–92
- Annigeri R, Conly J, Vas S et al. Emergence of mupirocin-re-sistant Staphylococcus aureus in chronic peritoneal dialysis pa-tients using mupirocin prophylaxis to prevent exit-site infection. Pent Dial Int 2001; 21: 554–9
- Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal car-riage. Ann Pharmacother 1998; 32: S7–16
- Davey P, Craig AM, Hau C, Malek M. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing perito-neal dialysis based on a randomized, placebo-controlled trial. J Antimicrob Chemother 1999; 43: 105–12